Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 2.72% | $13.73M | €458.08B | 67.61% | 76 Outperform | |
| Roche Holding AG | 1.66% | $8.37M | CHF294.92B | 46.36% | 73 Outperform | |
| AstraZeneca | 1.61% | $8.12M | $324.77B | 32.79% | 80 Outperform | |
| Novartis AG | 1.56% | $7.88M | CHF244.33B | 31.88% | 80 Outperform | |
| HSBC Holdings | 1.46% | $7.37M | £218.16B | 44.94% | 80 Outperform | |
| Nestlé SA | 1.30% | $6.57M | CHF199.86B | 12.45% | 71 Outperform | |
| Toyota Motor | 1.13% | $5.72M | ¥48.39T | 35.36% | 80 Outperform | |
| Mitsubishi UFJ Financial Group | 1.06% | $5.36M | ¥32.17T | 40.45% | 76 Outperform | |
| Siemens | 1.04% | $5.27M | €183.95B | 8.14% | 74 Outperform | |
| Commonwealth Bank of Australia | 1.04% | $5.24M | AU$297.63B | 11.29% | 64 Neutral |